Alviggi C, Vigilante L, Cariati F, Conforti A, Humaidan P
Reprod Biol Endocrinol. 2025; 23(Suppl 1):38.
PMID: 40059197
PMC: 11892182.
DOI: 10.1186/s12958-025-01361-8.
Wu N, Li X, Zeng C, Shang J, Yang X, Xue Q
J Ovarian Res. 2025; 18(1):47.
PMID: 40055770
PMC: 11889746.
DOI: 10.1186/s13048-025-01613-6.
Havrljenko J, Kopitovic V, Pjevic A, Milatovic S, Kalember S, Katanic F
Medicina (Kaunas). 2025; 61(2).
PMID: 40005420
PMC: 11857636.
DOI: 10.3390/medicina61020303.
Wang C, Feng Y, Chen Y, Lin X, Li X
Front Endocrinol (Lausanne). 2025; 16:1525392.
PMID: 39996063
PMC: 11847672.
DOI: 10.3389/fendo.2025.1525392.
Roberts L, Herlihy N, Reig A, Titus S, Garcia-Milian R, Knight J
Aging (Albany NY). 2025; 17(2):431-447.
PMID: 39976580
PMC: 11892918.
DOI: 10.18632/aging.206202.
Diminished ovarian reserve is associated to euploidy rate: a single center study.
Carnesi E, Castellano S, Albani E, Busnelli A, Smeraldi A, Bulbul O
Front Endocrinol (Lausanne). 2025; 15:1535776.
PMID: 39897960
PMC: 11783844.
DOI: 10.3389/fendo.2024.1535776.
Frozen versus fresh embryo transfer in women with low prognosis for in vitro fertilisation treatment: pragmatic, multicentre, randomised controlled trial.
Wei D, Sun Y, Zhao H, Yan J, Zhou H, Gong F
BMJ. 2025; 388:e081474.
PMID: 39880462
PMC: 11778674.
DOI: 10.1136/bmj-2024-081474.
Growth hormone improves the pregnancy outcomes in poor ovarian responders undergoing in vitro fertilization: an umbrella review.
Liu Y, Ding F, Yang Y, Ma B
J Assist Reprod Genet. 2025; .
PMID: 39862359
DOI: 10.1007/s10815-025-03389-6.
Metabolomics-Driven Insights into Biomarkers for Poor Ovarian Response: A Narrative Review.
Potiris A, Stavros S, Alyfanti E, Machairiotis N, Drakaki E, Zikopoulos A
Biomedicines. 2025; 13(1).
PMID: 39857797
PMC: 11762483.
DOI: 10.3390/biomedicines13010214.
ENDOCRINOLOGICAL AND GYNECOLOGICAL PARAMETERS IN ASSESSING INFERTILITY AT REPRODUCTIVE AGE.
Tanase A, Ciocoiu M, Tanase G
Acta Endocrinol (Buchar). 2025; 20(2):256-259.
PMID: 39845766
PMC: 11750217.
DOI: 10.4183/aeb.2024.256.
The most appropriate indicators of successful ovarian stimulation.
Roque M, Sunkara S
Reprod Biol Endocrinol. 2025; 23(Suppl 1):5.
PMID: 39789602
PMC: 11714799.
DOI: 10.1186/s12958-024-01331-6.
Intraovarian platelet-rich plasma injection significantly improves blastocyst yield and quality in IVF patients.
Yu T, Chen M, Lee T, Chen Y, Cheng E, Huang C
Sci Rep. 2025; 15(1):1301.
PMID: 39779754
PMC: 11711656.
DOI: 10.1038/s41598-024-82630-1.
Development and validation of a nomogram for failure to collect oocytes in POSEIDON Groups 3 and 4 undergoing IVF/ICSI treatment.
Ye T, Fan W, Du L, Bu Z, Li J, Kong H
Sci Rep. 2024; 14(1):31316.
PMID: 39732887
PMC: 11682411.
DOI: 10.1038/s41598-024-82783-z.
FSH/LH co-stimulation in Advanced Maternal Age (AMA) and hypo-responder patients - Arabian gulf delphi consensus group.
Awwad J, Peramo B, Elgeyoushi B, Melado L, Salame A, Chawla M
Front Endocrinol (Lausanne). 2024; 15:1506332.
PMID: 39726844
PMC: 11669953.
DOI: 10.3389/fendo.2024.1506332.
An update review of the application of single-cell RNA sequencing in pregnancy-related diseases.
Zhou Z, Yang X
Front Endocrinol (Lausanne). 2024; 15:1415173.
PMID: 39717096
PMC: 11663665.
DOI: 10.3389/fendo.2024.1415173.
Effect of pyridostigmine on growth hormone and IGF-1 levels and outcomes of controlled ovarian stimulation cycle in women with poor ovarian response.
Karimi R, Hadavi F, Jafarabadi M
Arch Gynecol Obstet. 2024; 311(1):175-182.
PMID: 39708173
DOI: 10.1007/s00404-024-07895-3.
How to balance the live birth rate and the multiple pregnancy rate by selecting the cleavage-stage embryo number and quality for POSEIDON Group 1 and Group 2? A retrospective study.
He H, Liu R, Zhang Q, Geng L, Hou Z, Xu C
Arch Gynecol Obstet. 2024; 311(2):507-517.
PMID: 39680145
PMC: 11890402.
DOI: 10.1007/s00404-024-07850-2.
Altered Immune Cell Profiles in the Follicular Fluid of Patients with Poor Ovarian Response According to the POSEIDON Criteria.
Zhou L, Zhao S, Luo J, Rao M, Yang S, Wang H
J Inflamm Res. 2024; 17:10663-10679.
PMID: 39677298
PMC: 11638477.
DOI: 10.2147/JIR.S473068.
Biallelic Germline Frameshift Mutations Associated with Isolated Diminished Ovarian Reserve.
Helbling-Leclerc A, Falampin M, Heddar A, Guerrini-Rousseau L, Marchand M, Cavadias I
Int J Mol Sci. 2024; 25(22).
PMID: 39596525
PMC: 11594631.
DOI: 10.3390/ijms252212460.
Dual trigger versus human chorionic gonadotropin trigger for blastocyst quality and cumulative live birth.
He Z, Liu Y, Huang N, Liu X, Zeng L, Lian Y
J Assist Reprod Genet. 2024; 41(12):3445-3453.
PMID: 39549203
PMC: 11707115.
DOI: 10.1007/s10815-024-03293-5.
